QuidelOrtho Corporation announced that the board has terminated Douglas Bryant, President. Mr. Bryant has also resigned from the Board, both effective February 21, 2024. In this transition, Robert Bujarski as the Interim President, effective February 21, 2024.

Kenneth F. Buechler, Ph.D., will remain as Chairman of the Board and will provide guidance to the Office of the CEO, supported by other Board members. Robert Bujarski has two decades of enterprise experience at the Company spanning the full spectrum of operational, commercial, and legal functions within the diagnostics sector. Robert also brings significant knowledge and expertise across strategy, business development and R&D. Prior to his current role, Robert was the Chief Operating Officer of Quidel Corporation (?Quidel?) from September 2020 to May 2022, where he architected expansions of Quidel?s operational scope and scale.